Summary: Researchers mapped a critical neural pathway that regulates how the body responds to dietary changes. The study centers on a liver hormone called FGF21.
While it was previously thought that metabolic control was dominated by other brain regions, this research identifies a specific group of neurons in the hindbrain as the essential “command center” for FGF21. These neurons detect protein levels in the diet and trigger immediate shifts in food choice, appetite, and calorie burning to maintain energy balance.
Key Facts
- The Protein Sensor: FGF21 is a hormone produced by the liver that acts as a signal to the brain when dietary protein is low.
- Hindbrain Revolution: The study proves that hindbrain neurons are both necessary and sufficient to drive metabolic adaptations. Without this specific circuit, the body cannot adjust its appetite or energy expenditure during protein restriction.
- Integrated System: These findings challenge the long-held belief that metabolism is primarily a “top-down” process from the hypothalamus, instead pointing to an integrated system where the hindbrain plays a leading role.
- Therapeutic Optimization: Because FGF21-based drugs are already in clinical trials for obesity and diabetes, this discovery suggests these treatments could be “tuned” to target brain circuits that specifically control eating behavior and metabolic rate.
Source: Pennington Biomedical Research Center
Researchers at Pennington Biomedical Research Center provide critical insight into how the brain and body work together to regulate food intake, energy use and metabolism – offering important new analysis into the biology of obesity and metabolic health.
The study, “FGF21 signals through hindbrain neurons to alter food intake and energy expenditure during dietary protein restriction,” published in the journal Cell Reports and led by Pennington Biomedical Associate Executive Director for Basic Science Dr. Christopher Morrison and colleagues, focuses on Fibroblast Growth Factor 21 (FGF21), a hormone produced by the liver that helps the body adapt to changes in diet and nutritional status.
Researchers identified a specific group of neurons in the hindbrain that respond directly to FGF21, acting as a key pathway through which the hormone influences eating behavior and energy balance. These neurons play a central role in adapting to dietary protein restriction by altering both food intake and energy expenditure.
The findings demonstrate that signaling through these hindbrain neurons is required to drive metabolic adaptations, including changes in appetite and calorie burning. This challenges long-standing assumptions that these processes are primarily controlled by other regions of the brain and points to a more complex, integrated system.
Research also shows that these neurons are both necessary and sufficient to drive changes in food intake, food choice and energy expenditure during protein restriction – underscoring their central role in maintaining energy balance.
“This work highlights how strongly nutrition is linked to brain function. The body is constantly monitoring what we eat and making ongoing adjustments, so understanding those signals is key to improving metabolic health,” said Dr. Morrison, who is co-director of the Neurosignaling Laboratory at Pennington Biomedical.
“These findings suggest that FGF21-based therapies could potentially be optimized to target specific brain circuits, and that clinical end points beyond liver fat, such as dietary behavior and metabolic rate, may be worth evaluating.”
Obesity, diabetes and related metabolic conditions continue to pose significant health challenges worldwide. Obesity and metabolic diseases are driven in part by disruptions in how the body regulates energy balance. By identifying the pathways that connect diet to brain function, researchers are gaining critical insight into how to better treat these conditions.
FGF21-based therapies are already being explored in clinical settings, and understanding how these therapies work at the neural level is essential for improving their effectiveness and minimizing side effects.
“This study is an excellent example of why basic science research is so important to improving human health,” said Dr. Jennifer Rood, Interim Senior Vice Chancellor and Executive Director of Pennington Biomedical.
“By uncovering how the brain and body communicate, our scientists are helping to build the foundation for new treatments for obesity and metabolic disease.”
Funding: This study was supported by funding through the National Institutes of Health, and the authors would also like to thank the leadership and staff of the Pennington Biomedical Comparative Biology Core and Animal Metabolism and Behavior Core for their skillful assistance and excellent technical support.
In addition to Dr. Morrison, other researchers from Pennington Biomedical included Drs. Redin Spann, Sora Kim, Shahjalal Khan, Diana Albarado, Sun Fernandez-Kim, Hans-Rudolf Berthoud, David McDougal, Heike Münzberg-Gruening, Yanlin He and Sangho Yu.
Key Questions Answered:
A: Protein is essential for survival. When your intake drops, your liver releases FGF21 to tell your brain to change your behavior. This circuit can make you crave protein-rich foods and even change how many calories your body burns at rest to compensate for the nutritional shift.
A: FGF21 therapies are already being tested. The breakthrough here is knowing where in the brain they work. By targeting the hindbrain, future drugs might be able to boost metabolism and curb cravings more effectively with fewer side effects.
A: That’s the old way of thinking. This research elevates the hindbrain to a sophisticated metabolic regulator that monitors the chemical makeup of your blood and dictates complex behaviors like food choice.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this neuroscience and metabolism research news
Author: Ernie Ballard
Source: Pennington Biomedical Research Center
Contact: Ernie Ballard – Pennington Biomedical Research Center
Image: The image is credited to Neuroscience News
Original Research: Closed access.
“FGF21 signals through hindbrain neurons to alter food intake and energy expenditure during dietary protein restriction” by Redin A. Spann, Sora Q. Kim, Md Shahjalal H. Khan, Diana A. Albarado, Sun O. Fernandez-Kim, Hans-Rudolf Berthoud, David H. McDougal, Heike Münzberg, Yanlin He, Sangho Yu, and Christopher D. Morrison. Cell Reports
DOI:10.1016/j.celrep.2026.117218
Abstract
FGF21 signals through hindbrain neurons to alter food intake and energy expenditure during dietary protein restriction
The metabolic hormone fibroblast growth factor 21 (FGF21) is essential for adaptive responses to dietary protein restriction, but the precise neural circuit mediating these effects remains undefined.
Here, we demonstrate that a discrete population of glutamatergic, Klb-expressing neurons in the nucleus of the solitary tract (NTS) mediates FGF21 action during protein restriction. Using a Klb-Flp mouse line combined with intersectional genetics, we show that NTS-beta-klotho (KLB) neurons are directly activated by FGF21.
Systematic evaluation of previously implicated regions (suprachiasmatic nucleus [SCN], paraventricular nucleus [PVN], and ventromedial hypothalamus [VMH]) reveals these areas are not required for FGF21-mediated responses to protein restriction.
In contrast, selective ablation of NTS-KLB neurons prevents metabolic adaptations to protein restriction, including changes in food intake, food choice, and energy expenditure, while their chemogenetic activation is sufficient to drive these responses.
These findings establish that NTS-KLB neurons directly respond to FGF21 and coordinate adaptive changes during protein restriction, identifying the neural circuit linking dietary protein sensing to metabolic adaptation.
